Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

Fig. 1

Effect of 6-month treatment with IGB in BDI (a*), HADS-D (b**) and HADS-A scores (c***). IGB intragastric balloon; BDI Beck Depression Inventory; HADS hospital anxiety and depression scale; HADS-A hospital anxiety and depression scale-anxiety; HADS-D hospital anxiety and depression scale-depression; * p = 0.002; ** p = 0.0345; *** p = 0.0066

Back to article page